News Archive

Less than 30% of heart attack patients treated with cangrelor received the treatment in a way that was consistent with established protocols and the drug’s FDA labeling, according to new research from the Duke Clinical Research Institute using the CAMEO registry.

Medicare patients whose implantable heart devices became infected were less likely to die from the complication if they had the hardware removed compared to patients who only received antibiotics, according to the largest study on the topic, led by the Duke Clinical Research Institute.

A new type of anti-clotting drug caused fewer bleeding incidents among patients with atrial fibrillation than the commonly prescribed apixaban, according to results from a head-to-head comparison of the two.

Heart failure patients taking the investigational drug omecamtiv mecarbil, which has been previously shown to improve long-term outcomes, see little impact on their ability to exercise compared to a placebo, according to a study supported by the Duke Clinical Research Institute.

Less than half of the patients with first-detected atrial fibrillation (AFib) receive rhythm control at admission, according to data analysis from the nationwide Get With The Guidelines®-Atrial Fib

School districts that required masking saw lower rates of COVID-19 transmission within schools last fall compared to those with optional masking policies, according to a study by the ABC Science Collaborative.

A pragmatic, open-label, randomized trial of 1,201 patients found as-needed use of inhaled glucocorticoids plus existing therapy improved asthma outcomes in a broad population of Black and Latinx patients with poorly controlled asthma.

Healthcare workers who have children under age 5 are twice as likely as other parents to plan to vaccinate their children against COVID-19, according to a new poll conducted by the HERO Registry coordinated by the Duke Clinical Research Institute.

Web and phone-based enrollment allows people to help test potential COVID-19 treatments without leaving home.

The pragmatic clinical trial was the first demonstration project of PCORnet®, the Patient-Centered Clinical Research Network, which is an integrated partnership of clinical research networks funded by the Patient-Centered Outcomes Research Institute (PCORI).